different stages through Can be repeatedly Gossop and Strang are key treatment designed as an administered at points players in the Not relevant for – outcome research tool. during and after an index RECOVEU as too long in treatment episode. Changes Reference as: Marsden, J., this format. The MAP measures in these measures can then Gossop, M., Stewart, D., problems in 4 domains: be attributed to treatment Best, D., Farrell, M., substance use, health risk or other processes over the Lehmann, P., Edwards, C. behaviour, physical and intervening period. and Strang, J. (1998). The psychological health, and Maudsley Addiction Profile personal/social (MAP): A instrument functioning. for assessing treatment outcome. Addiction, 93(12), 1857-1867. EuropASI Cyprus (Yes This is a lengthy client entering the This tool originated in the For information and ASI is in the public – ‘The European have assessment tool that inpatient phase of United States and is one of instrument see: domain’ so can put link – – Addiction accessed covers: social history, treatment. the most widely used and to provide to this on RECOVEU site. ‘Designed Severity Index through educational, family, judicial EUROPASI can be used well researched testing basic diagnostic ‘The (Based on the EMCDDA system, substance abuse, for different purposes in tools around the world for information on a client Too lengthy for RECOVEU Addiction instrument physical and sexual abuse assessing substance substance abuse. prior, during and after purposes and not Severity Index) list) history and employment clients: a) to assess the treatment for report. history of the last 30 days, problem severity of the substance use-related 90 days and 1 year. interviewee, and b) for problems, and for the Face-to-face structured periodic repeated assessment of change interview. administrations to monitor in client status and and quantify change in treatment outcome.’
different stages through treatment – designed as an outcome research tool. The MAP measures problems in 4 domains: substance use, health risk behaviour, physical and psychological health, and personal/social functioning. Can be repeatedly administered at points during and after an index treatment episode. Changes in these measures can then be attributed to treatment or other processes over the intervening period. Gossop and Strang are key players in the Reference as: Marsden, J., Gossop, M., Stewart, D., Best, D., Farrell, M., Lehmann, P., Edwards, C. and Strang, J. (1998). The Maudsley Addiction Profile (MAP): A instrument for assessing treatment outcome. Addiction, 93(12), 1857-1867. Not relevant for RECOVEU as too long in this format. EuropASI – European Addiction Severity Index (Based on the Addiction Severity Index) Cyprus (Yes – have accessed through EMCDDA instrument list) This is a lengthy assessment tool that covers: social history, educational, family, judicial system, substance abuse, physical and sexual abuse history and employment history of the last 30 days, 90 days and 1 year. Face-to-face structured interview. client entering the inpatient phase of treatment. ‘The EUROPASI can be used for different purposes in assessing substance clients: a) to assess the problem severity of the interviewee, and b) for periodic repeated administrations to monitor and quantify change in This tool originated in the United States and is one of the most widely used and well researched testing tools around the world for substance abuse. For information and instrument see: ‘Designed to provide basic diagnostic information on a client prior, during and after treatment for substance use-related problems, and for the assessment of change in client status and treatment outcome.’ ‘The ASI is in the public domain’ – so can put link to this on RECOVEU site. Too lengthy for RECOVEU purposes and not report.
Del%206.1_Evaluation%20Approach%20Review_FINAL_Dec%202016.docx